Tværgående DTU forskning
En ny type kræftbehandling med immunterapi er ved at blive udviklet på DTU Nanotech og vil blive realiseret gennem spin-out-virksomheden MonTa Biosciences...
The continued downscaling of transistors reaches around 10 nanometers in the near future. Researchers from DTU Nanotech pursue even smaller devices - going towards 5 nm...
Three projects rooted at DTU Nanotech have received funding from the Danish Council for Independent Research.
In August 2015 a brand new course in high tech entrepreneurship rooted at DTU Nanotech was held for the first time. During three intensive weeks, bachelor students teamed...
A quick screening to find the most optimal combination of chemotherapy drugs for the individual cancer patient may soon be a reality, thanks to newly developed Lab-on-a...
Associate Professor Stephan Sylvest Keller has received the Microelectronic Engineering (MEE) Young Investigator Award and Lectureship. The award was presented at the Micro...
The research project SMARTDIAGNOS from DTU Nanotech receives a large EU grant for the development of a device which will enable faster diagnosis of sepsis.
DTU Nanotech participates in a new consortium which will investigate novel treatments for Parkinson’s disease.
At an award ceremony held on 26 August by the Capital Region of Denmark, DTU Nanotech had its Global Excellence status renewed for a period of 5 years.
Researchers from DTU Nanotech and Columbia University have developed a new platform which enhances greatly the electrical performance of 2D materials.